The development and validation of the malaysian medication Adherence scale (MALMAS) among patients with 2 type diabetes in Malaysia

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 5, Issue 3, 2013, Pages 790-794

  Chua, Siew Siang ^a   Lai, Pauline Siew Mei ^a,b   Tan, Ching Hooi ^b   Chan, Siew Pheng ^a   Chung, Wen Wei ^a,b   Morisky, Donald E ^c  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

MALMAS; Medication adherence; MMAS; Reliability; Validation

Indexed keywords

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONCURRENT VALIDITY; CORRELATION ANALYSIS; FEMALE; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALAYSIA; MALAYSIAN MEDICATION ADHERENCE SCALE; MALE; MEDICATION COMPLIANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; SAMPLE SIZE; SCORING SYSTEM; TEST RETEST RELIABILITY;

EID: 84879943269     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Anonymous. Adherence to long term therapies: Evidence for action. World Health Organisation 2003, Switzerland. Available from: http://www.who.int/chp/knowledge/ publications/adherence_full_report.pdf, accessed on 6 March 2013.
2. Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care 2004; 27(5):1218-24.
3. Odegard PS, Capoccia K. Medication taking and diabetes: a systematic review of the literature. Diabetes Educ 2007; 33(6):1014-31.
4. Bharmal M, Payne K, Atkinson MJ, Desrosiers MP, Morisky DE, Gemmen E. Validation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihypertensive medications. Health Qual Life Outcomes 2009; 7:36.
5. Balkrishnan R, Rajagopalan R, Camacho FT, Huston SA, Murray FT, Anderson RT. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther 2003; 25(11):2958-71.
6. Lerman I. Adherence to treatment: the key for avoiding long-term complications of diabetes. Arch Med Res 2005; 36(3):300-6.
7. Laditka SB, Mastanduno MP, Laditka JN. Health Care Use of Individuals With Diabetes in an Employer-Based Insurance Population. Arch Intern Med 2001; 161: 1301-1308.
8. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005; 43(6): 521-30.
9. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345(19):1359-67.
10. Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med 2006; 166(17):1836-41.
11. Lau DT, Nau DP. Oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes. Diabetes Care 2004; 27(9):2149-53.
12. Melikian C, White TJ, Vanderplas A, Dezii CM, Chang E. Adherence to oral antidiabetic therapy in a managed care organization: a comparison of monotherapy, combination therapy, and fixed-dose combination therapy. Clin Ther 2002; 24(3):460-7.
13. Simmons D, Peng A, Cecil A, Gatland B. The personal costs of diabetes: a significant barrier to care in South Auckland. NZ Med J 1999; 112(1097):383-5.
14. Donnan PT, MacDonald TM, Morris AD. Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study. Diabetic Med 2002; 19(4):279-84.
15. Browne DL, Avery L, Turner BC, Kerr D, Cavan DA. What do patients with diabetes know about their tablets? Diabetic Med 2000; 17(7):528-31.
16. Hanchak NA, Patel MB, Berlin JA, Strom BL. Patient misunderstanding of dosing instructions. J Gen Intern Med 1996; 11(6):325-8.
17. Kravitz RL, Hays RD, Sherbourne CD, DiMatteo MR, Rogers WH, Ordway L, et al. Recall of recommendations and adherence to advice among patients with chronic medical conditions. Arch Intern Med 1993; 153(16):1869-78.
18. Cohen JS. Adverse drug effects, compliance, and initial doses of antihypertensive drugs recommended by the Joint National Committee vs the Physicians' Desk Reference. Arch Intern Med 2001; 161(6):880-5.
19. Grant RW, Devita NG, Singer DE, Meigs JB. Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care 2003; 26(5):1408-12.
20. Krousel-Wood M, Thomas S, Muntner P, Morisky D. Medication adherence: A key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol 2004; 19(4):357-62.
21. Morisky DE, Malotte CK, Choi P, Davidson P, Rigler S, Sugland B, et al. A patient education program to improve adherence rates with antituberculosis drug regimens. Health Educ Behav 1990; 17(3):253-67.
22. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich) 2008; 10(5):348-54.
23. Da P, Shafa LE, Sutmonbara EY, Supadmi W. Risk factors associated with outpatients adherence in taking refill of oral hypoglycaemic drugs in the provate and government hospitals, Indonesia. Int J Pharm Pharm Sci. 2010; 2(2):134-5.
24. Shariff A, Al Dhubiab BE, Al Nowis M, Al Haddad F, Al Omran N, Al Khuliteet H. Statistical investigatin of patient factor in development of antibiotic resistance-a study in Eastern Province of Saudi Arabia. Int J Pharm Pharm Sci. 2013; 5(2):152-6.
25. Vik S, Maxwell C, Hogan D, Patten S, Johnson J, Slack L. Assessing medication adherence among older persons in community settings. Can J Clin Pharmacol 2005; 12(1):e152-e164.
26. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353(5):487-97.
27. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24(1):67-74.
28. Morisky DE, DiMatteo MR. Improving the measurement of self-reported medication nonadherence: Response to authors. J Clin Epidemiol 2011; 64(3):255-63.
29. Krousel-Wood M, Islam T, Webber LS, Re RN, Morisky DE, Muntner P. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care 2009; 15(1):59-66.
30. Lu M, Safren SA, Skolnik PR, Rogers WH, Coady W, Hardy H, et al. Optimal recall period and response task for self-reported HIV medication adherence. AIDS Behav 2008; 12(1):86-94.
31. Sodergard B, Halvarsson M, Tully MP, Mindouri S, Nordstrom ML, Lindback S, et al. Adherence to treatment in Swedish HIV-infected patients. J Clin Pharm Ther 2006; 31(6):605-16.
32. Altman DG. Practical statistics for medical research, New York: Chapman & Hall / CRC Press; 1999.
33. Gorsuch RL. Factor Analysis, 2nd ed. Hillsdale, New Jersey: Erlbaum Associates; 1983.
34. Bowling A. Research Methods in Health: Investigating health and health services, 3rd ed. Berkshire, England: Open University Press; 2009.
35. Sushil S, Verma N. Questionnaire validation made easy. Eur J Scientific Res 2010; 46(2):172-8.
36. Streiner DL, Norman GR. Health measurement scales. A practical guide to their development and use, 2nd ed. New York: Oxford University Press Inc.; 1995.
37. DeVellis RF. Scale development: Theory and applications, Vol. 26. Thousand Oaks, California: Sage Publications, Inc.; 2003.
38. Cohen JS. Statistical power analysis for the Behavioural Sciences, 2nd ed. New Jersey: Lawrence Erlbaum Associates, Inc.; 1988.
39. Al-Qazaz H, Hassali MA, Shafie AA, Sulaiman SA, Sundram S, Morisky DE. The eight-item Morisky Medication Adherence Scale MMAS: Translation and validation of the Malaysian version. Diabetes Res Clin Pract 2010; 90(2):216-21.